MYGN insider transactions
Myriad Genetics Inc. (MYGN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
MYGN insiders
Everyone who has filed a Form 3, 4, 5 or 144 at Myriad Genetics Inc., latest first. Follow anyone to get their next filing.
- Raj JampaChief Technology Officer, since June 2026
- Shereen SolaimanChief People Officer, since March 2023
- Vishal SikriEVP, Commercial, since September 2026
- Dale MuzzeyChief Scientific Officer, since April 2022-$55K
- Jennifer Lynne FoxChief Legal & Corp Strategy, since September 2024
- Mark VerrattiChief Operating Officer
- Benjamin Richard WheelerChief Financial Officer, since August 2025
- Brian J DonnellyChief Commercial Officer, since May 2025
- Daniel SkovronskyDirector
- Samraat S. RahaPresident and CEO, Director, since December 2023+$200K
- Rashmi KumarDirector-$277K
- Lee Nisley NewcomerDirector-$157K
- Mark Steven DavisDirector, since December 2024
- S. Louise PhanstielDirector+$495K-$1.68M
- Colleen F ReitanDirector-$1.29M
- Heinrich DreismannDirector-$271K
- Paul BisaroDirector, since October 2022+$27.6K
- Kevin Richard HaasChief Technology Officer, since February 2021
- Margaret AnconaEVP, Strategy & Transformation, since February 2021-$321K
- Natalie MunkChief Accounting Officer, since June 2022
- Scott J. LefflerChief Financial Officer, since January 2024
- Paul J DiazPresident and CEO, Director-$6.47M
- Daniel K SpiegelmanDirector-$585K
- Pamela WongChief Legal Officer, since October 2021
- Richard Bryan RiggsbeeChief Financial Officer-$2.07M
- Nicole LambertOfficer, since April 2019-$743K
- Jayne B. HartOfficer, since September 2020-$4.28M
- Dennis LangerDirector-$1.04M
- Eric SantaOfficer, since April 2021
- Jerry S LanchburyOfficer-$20.3M
- Heinrich DreismannDirector
- Benjamin JacksonOfficer
- Paul ParkinsonOfficer
Recent Form 3, 4, and 5 filings for MYGN
- Chief Technology Officer Jampa Raj was granted 58,560 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief People Officer Solaiman Shereen was granted 83,049 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- EVP, Commercial Sikri Vishal was granted 53,236 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Scientific Officer Muzzey Dale was granted 92,632 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Legal & Corp Strategy Fox Jennifer Lynne was granted 139,267 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Operating Officer Verratti Mark was granted 146,933 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard was granted 121,379 time-based stock options (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Legal & Corp Strategy Fox Jennifer Lynne was granted 39,370 shares, increasing direct ownership by 13% to 345,334 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 2,555 shares, decreasing direct ownership by 0.88% to 287,193 units (SEC Form 4) to cover taxes4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Chief Commercial Officer Donnelly Brian J4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- EVP, Commercial Sikri Vishal was granted 257,731 shares, increasing direct ownership by 276% to 351,224 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- New insider Sikri Vishal claimed ownership of 93,493 shares (SEC Form 3)3 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Legal Officer Fox Jennifer Lynne covered exercise/tax liability with 4,398 shares, decreasing direct ownership by 1% to 305,964 units (SEC Form 4) to satisfy withholding tax4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 8,761 shares, decreasing direct ownership by 3% to 289,748 units (SEC Form 4) (for tax liability)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Director Skovronsky Daniel4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- President and CEO Raha Samraat S. was granted 3,542 shares, increasing direct ownership by 0.33% to 1,068,083 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Commerical Officer Donnelly Brian J was granted 5,000 shares, increasing direct ownership by 0.88% to 573,363 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Kumar Rashmi sold $66,843 worth of shares (15,000 units at $4.46) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 171,889 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Skovronsky Daniel was granted 59,701 shares, increasing direct ownership by 44% to 195,507 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Newcomer Lee Nisley was granted 59,701 shares, increasing direct ownership by 45% to 191,842 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Davis Mark Steven was granted 59,701 shares, increasing direct ownership by 127% to 106,665 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Phanstiel S. Louise was granted 59,701 shares, increasing direct ownership by 21% to 341,652 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Dreismann Heinrich was granted 59,701 shares, increasing direct ownership by 35% to 231,145 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Reitan Colleen F was granted 59,701 shares, increasing direct ownership by 65% to 152,030 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Bisaro Paul was granted 59,701 shares, increasing direct ownership by 61% to 157,142 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Kumar Rashmi was granted 59,701 shares, increasing direct ownership by 47% to 186,889 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Technology Officer Jampa Raj was granted 251,889 shares (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 3 filed by new insider Jampa Raj3 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Bisaro Paul bought $27,638 worth of shares (7,500 units at $3.69), increasing direct ownership by 8% to 97,441 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Commerical Officer Donnelly Brian J covered exercise/tax liability with 55,975 shares, decreasing direct ownership by 9% to 568,363 units (SEC Form 4) to satisfy withholding tax4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Verratti Mark4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Muzzey Dale4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Verratti Mark4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Muzzey Dale4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Wheeler Benjamin Richard4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Technology Officer Haas Kevin Richard covered exercise/tax liability with 22,310 shares, decreasing direct ownership by 11% to 180,022 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Scientific Officer Muzzey Dale was granted 173,196 shares and covered exercise/tax liability with 37,799 shares, increasing direct ownership by 70% to 329,275 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief People Officer Solaiman Shereen was granted 173,196 shares and covered exercise/tax liability with 14,683 shares, increasing direct ownership by 145% to 267,801 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Legal Officer Fox Jennifer Lynne was granted 195,876 shares and covered exercise/tax liability with 5,995 shares, increasing direct ownership by 158% to 310,362 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Operating Officer Verratti Mark was granted 247,423 shares and covered exercise/tax liability with 29,289 shares, increasing direct ownership by 53% to 632,770 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Commerical Officer Donnelly Brian J was granted 226,804 shares, increasing direct ownership by 57% to 624,338 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard was granted 206,186 shares and covered exercise/tax liability with 4,752 shares, increasing direct ownership by 206% to 299,058 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- President and CEO Raha Samraat S. covered exercise/tax liability with 47,120 shares and was granted 618,557 shares, increasing direct ownership by 116% to 1,064,541 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- President and CEO Raha Samraat S. bought $199,844 worth of shares (40,000 units at $5.00), increasing direct ownership by 9% to 493,104 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief People Officer Solaiman Shereen covered exercise/tax liability with 1,675 shares, decreasing direct ownership by 2% to 109,288 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Director Phanstiel S. Louise bought $494,722 worth of shares (104,507 units at $4.73), increasing direct ownership by 59% to 281,951 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Operating Officer Verratti Mark was granted 32,810 shares, increasing direct ownership by 9% to 414,636 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard was granted 4,994 shares, increasing direct ownership by 5% to 97,624 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Technology Officer Haas Kevin Richard was granted 23,697 shares, increasing direct ownership by 13% to 202,332 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Scientific Officer Muzzey Dale was granted 23,697 shares, increasing direct ownership by 14% to 193,878 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Scientific Officer Muzzey Dale covered exercise/tax liability with 418 shares, decreasing direct ownership by 0.25% to 170,181 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 21 shares, decreasing direct ownership by 0.02% to 92,630 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- President and CEO Raha Samraat S. covered exercise/tax liability with 29,634 shares, decreasing direct ownership by 6% to 453,104 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by EVP, Strategy & Transformation Ancona Margaret4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- SEC Form 4 filed by Chief Accounting Officer Munk Natalie4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Operating Officer Verratti Mark covered exercise/tax liability with 1,085 shares, decreasing direct ownership by 0.28% to 381,826 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Accounting Officer Munk Natalie covered exercise/tax liability with 962 shares, decreasing direct ownership by 2% to 45,167 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Financial Officer Wheeler Benjamin Richard covered exercise/tax liability with 2,559 shares, decreasing direct ownership by 3% to 92,651 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- EVP, Strategy & Transformation Ancona Margaret covered exercise/tax liability with 958 shares, decreasing direct ownership by 0.74% to 127,726 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)
- Chief Legal Officer Fox Jennifer Lynne covered exercise/tax liability with 4,435 shares, decreasing direct ownership by 4% to 120,481 units (SEC Form 4)4 - MYRIAD GENETICS INC (0000899923) (Issuer)